Coleson v. Qualitest Pharmaceutical Manufacture et al, No. 1:2017cv05381 - Document 48 (S.D.N.Y. 2018)

Court Description: MEMORANDUM OPINION AND ORDER re: 32 MOTION to Dismiss filed by Endo Pharmaceutical, Qualitest Pharmaceutical Manufacture, 35 LETTER MOTION for Oral Argument on Teva Pharmaceutical USA, Inc's Motion to Dismiss a ddressed to Judge John G. Koeltl from Lewis A Bartell dated January 3, 2018 filed by Teva Pharmaceutical USA, 38 LETTER MOTION for Oral Argument addressed to Judge John G. Koeltl from Matthew Mulqueen dated 01.03.2018 filed by En do Pharmaceutical, Qualitest Pharmaceutical Manufacture, 30 MOTION to Dismiss filed by Teva Pharmaceutical USA. The Court has considered all the parties' arguments. To the extent any arguments are not specifically addressed ab ove, they are either moot or without merit. The defendants' motion to dismiss the Amended Complaint is granted and the case is dismissed with prejudice. The Clerk of Court is directed to close all pending motions. SO ORDERED. (Signed by Judge John G. Koeltl on 5/4/2018) (mml)

Download PDF
Coleson v. Qualitest Pharmaceutical Manufacture et al Doc. 48 Dockets.Justia.com

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.